Search alternatives:
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
teer decrease » greater decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
teer decrease » greater decrease (Expand Search)
gap decrease » a decrease (Expand Search), gain decreased (Expand Search), step decrease (Expand Search)
-
621
Advanced experimental investigation of explosive characteristics in premixed syngas/air mixtures using a narrow gap disk burner
Published 2025“…The results show that the folding of the flame front is enhanced as the Φ decreases. However, the change in fold degree is negligible when the Φ decreases from 1.6 to 1.2. …”
-
622
-
623
-
624
-
625
-
626
Baseline Characteristics of Study Participants Stratified by Sleep Duration Categories.
Published 2025Subjects: -
627
Incidence of New-Onset Cardiovascular Disease in 2018 Follow-up by Sleep Duration Groups.
Published 2025Subjects: -
628
Subgroup Analysis of Sleep Duration and Cardiovascular Disease Risk in Type 2 Diabetes Patients.
Published 2025Subjects: -
629
-
630
-
631
-
632
-
633
-
634
-
635
-
636
Effect of the smoking factor on lung function parameters (FVC, FEV1, PEF, FEF 25_75).
Published 2025Subjects: -
637
-
638
<b> </b> Rate of brain weight to body weight in different experimental groups. AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate....
Published 2025“…AlCl3 treatment caused a significant decrease in brain-to-body weight with respect to the control group (P < 0.01). 2 or 5 injections of BM-MSC extracted exosomes significantly protected against the deficit effect of Alcl3 on brain-to-body weight rate. …”
-
639
-
640
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…Results are presented as mean ± SD. Ceramide: CER, Evogliptin: EVO. *(P < 0.05) significant vs. control group; <sup>$</sup>(P < 0.05) significant vs. …”